Company intelligence / Profile preview

Connemara Biomedical Holdings

Spiddal, Galway, Ireland

Ownership: Private
Employees: ~130
Development stage: Other

Overview

Connemara Biomedical Holdings (via its subsidiaries Aran Biomedical and Proxy Biomedical) provided advanced biomaterial technologies for implantable cardiovascular and other medical devices. At its acquisition in April 2022 by Integer Holdings for approximately $131 million, it was a recognized leader in its segment, generating $17 million in 2021 sales, nearly doubling from the prior year. The company is now inactive as an independent entity, with its technologies and team integrated into Integer Holdings.

Therapeutic areas: CardiovascularNeurologyOther
Modalities: BiologicDevicePolymerAdvanced metal braidingMedical textile
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Connemara Biomedical Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Connemara Biomedical Holdings.

Explore the full profile